12/09/2011
BioSpecifics Technologies Corp. Announces Appointment of George Gould to Board of Directors
11/09/2011
BioSpecifics Technologies Corp. to Present at Lazard Capital Markets 8th Annual Healthcare Conference
11/08/2011
BioSpecifics Technologies Corp. Reports Third Quarter 2011 Financial Results
11/01/2011
BioSpecifics Technologies Corp. to Host Conference Call to Report Third Quarter 2011 Financial Results on November 8, 2011
09/01/2011
BioSpecifics Technologies Corp. Announces Presentations at Three Upcoming Investor Conferences in September
08/31/2011
Auxilium Pharmaceuticals, Inc. and BioSpecifics Technologies Corp. Announce Plans to Develop Additional Indications using XIAFLEX®
08/09/2011
BioSpecifics Technologies Corp. Reports Second Quarter 2011 Financial Results
08/02/2011
BioSpecifics Technologies Corp. to Host Conference Call to Report Second Quarter 2011 Financial Results on August 9, 2011
06/20/2011
BioSpecifics Technologies Corp. Announces Board Authorization of up to $2 Million Share Repurchase Program
06/02/2011
BioSpecifics Technologies Corp. to Present at Jefferies 2011 Global Healthcare Conference
06/01/2011
BioSpecifics Announces Positive XIAPEX® Data Presented at XVI Annual Federation of European Societies for Surgery of the Hand Congress
05/20/2011
BioSpecifics Technologies Corp. Provides Update on XIAPEX® Launch Progress in EU
05/18/2011
BioSpecifics Technologies Corp. Announces Data Presentations at Upcoming XVI Annual Federation of the European Societies for Surgery of the Hand Meeting
05/11/2011
BioSpecifics Technologies Corp. to Present at SEVEN, Noble Financial Capital Markets' Seventh Annual Equity Conference
05/10/2011
BioSpecifics Technologies Corp. Reports First Quarter 2011 Financial Results
05/04/2011
BioSpecifics Technologies Corp. to Host Conference Call to Report First Quarter 2011 Financial Results
04/13/2011
BioSpecifics Technologies Corp. to Present at BioCentury Future Leaders in the Biotech Industry Conference
04/11/2011
BioSpecifics Technologies Corp. Announces Launch of XIAPEX® by Pfizer for Treatment of Dupuytren’s Contracture in Europe
03/11/2011
BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2010 Financial Results
03/10/2011
BioSpecifics Technologies Corp. to Present at the Roth Capital Partners 23rd Annual OC Growth Stock Conference
03/08/2011
BioSpecifics Technologies Corp. to Host Conference Call to Report Fourth Quarter and Full Year 2010 Financial Results on March 11, 2011
03/03/2011
BioSpecifics Technologies Corp. to Present at Cowen and Company 31st Annual Health Care Conference
03/01/2011
BioSpecifics Technologies Corp. Announces Approval of XIAPEX® for Treatment of Dupuytren’s Contracture in Europe
02/07/2011
BioSpecifics Technologies Corp. Amends Rights Agreement
01/06/2011
BioSpecifics Announces Positive Results From Clinical Trial in Canine Lipomas
12/07/2010
XIAFLEX® CORD II Study Published in The Journal of Hand Surgery
11/10/2010
BioSpecifics Technologies Corp. to Present at Lazard Capital Markets 7th Annual Healthcare Conference
11/08/2010
BioSpecifics Technologies Corp. Reports Third Quarter 2010 Financial Results
11/03/2010
BioSpecifics Technologies Corp. Awarded Two Qualifying Therapeutic Discovery Project Grants
11/01/2010
BioSpecifics Technologies Corp. to Host Conference Call to Report Third Quarter 2010 Financial Results on November 8, 2010
10/14/2010
BioSpecifics Technologies Corp. to Present at BioCentury Newsmakers in the Biotech Industry Conference
10/12/2010
BioSpecifics Technologies Corp. Announces Initiation of Global Phase 3 Trial of XIAFLEX® for Treatment of Peyronie’s Disease
09/14/2010
BioSpecifics Technologies Corp. to Present at UBS Global Life Sciences Conference
09/08/2010
BioSpecifics Technologies Corp. to Present at Rodman & Renshaw 12th Annual Healthcare Conference
08/06/2010
BioSpecifics Technologies Corp. Reports Second Quarter 2010 Financial Results
07/30/2010
BioSpecifics Technologies Corp. to Host Conference Call to Report Second Quarter 2010 Financial Results on August 6, 2010
07/12/2010
BioSpecifics Technologies Corp. Announces Auxilium XIAFLEX® Update
06/04/2010
BioSpecifics Technologies Corp. Announces Board Authorization of up to $2 Million Share Repurchase Program
06/02/2010
BioSpecifics Technologies Corp. to Present at Jefferies & Company 2010 Global Life Sciences Conference
05/07/2010
BioSpecifics Technologies Corp. Reports First Quarter 2010 Financial Results
05/03/2010
BioSpecifics Technologies Corp. to Host Conference Call to Report First Quarter 2010 Financial Results on May 7, 2010
03/25/2010
BioSpecifics Technologies Corp. Announces 2010 Annual Meeting Date and Proposal to Increase the Number of Authorized Shares of Common Stock
03/10/2010
BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2009 Financial Results
03/08/2010
BioSpecifics Technologies Corp. Announces Availability of XIAFLEX™ for the Treatment of Dupuytren's Contracture
03/05/2010
BioSpecifics Technologies Corp. to Host Conference Call to Report Fourth Quarter and Full Year 2009 Financial Results on March 10, 2010
03/01/2010
BioSpecifics Technologies Corp. to Present at Cowen and Company 30th Annual Health Care Conference
02/02/2010
BioSpecifics Technologies Corp. Announces FDA Approval of XIAFLEX™ for Treatment of Dupuytren’s Contracture
01/21/2010
BioSpecifics Technologies Corp. Announces Commencement of European Regulatory Review of XIAFLEX™ for the Treatment of Dupuytren’s Disease
12/16/2009
BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX™ for Treatment of Peyronie’s Disease
11/24/2009
BioSpecifics Technologies Corp. to Present at the Piper Jaffray 21st Annual Health Care Conference
11/06/2009
BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results
10/30/2009
BioSpecifics Technologies Corp. to Host Conference Call to Report Third Quarter 2009 Financial Results on November 5, 2009
09/16/2009
BioSpecifics Technologies Corp. Stock Trading Halted Today
09/16/2009
FDA Advisory Committee Unanimously Recommends Approval of XIAFLEX™ for Treatment of Dupuytren’s Disease
09/11/2009
BioSpecifics Technologies Corp. to Present at BioCentury “NewsMakers in the Biotech Industry” Conference
09/03/2009
BioSpecifics Technologies Corp. to Present at Rodman & Renshaw 11th Annual Healthcare Conference
09/03/2009
BioSpecifics Technologies Corp. Announces XIAFLEX™ CORD I Study Published in New England Journal of Medicine
08/12/2009
BioSpecifics Technologies Corp. Reports Second Quarter 2009 Financial Results
08/04/2009
BioSpecifics Technologies Corp. to Host Conference Call to Report Second Quarter 2009 Financial Results on August 12, 2009
07/22/2009
BioSpecifics Technologies Corp. to Present at CapStone Investments’ Third Annual Small-Cap Investor Conference
06/29/2009
BioSpecifics Technologies Corp. Added to Russell 3000 and Russell 2000 Indexes
05/10/2009
BioSpecifics Technologies Corp. Reports First Quarter 2009 Financial Results
04/27/2009
BioSpecifics Technologies Corp. Announces FDA Acceptance of Biologics License Application With Priority Review for XIAFLEX(TM) for the Treatment of Dupuytren's Disease
03/29/2009
BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2008 Financial Results
01/05/2009
BioSpecifics Technologies Corp. Announces Listing on NASDAQ Global Market
12/17/2008
BioSpecifics Announces Partnership Between Pfizer and Auxilium for XIAFLEX™ in Europe
11/19/2008
BioSpecifics Technologies Corp. to Present at Piper Jaffray 20th Annual Health Care Conference
09/24/2008
BioSpecifics Technologies Corp. Announces Appointment of Dr. Matthew Geller to Board of Director
09/16/2008
BioSpecifics Technologies Corp. Announces Initiation of Phase IIb Trial for Peyronie's Disease
09/04/2008
BioSpecifics Technologies Corp. Buys Down Royalties for Peyronie's Disease
08/19/2008
BioSpecifics Technologies Corp. Announces Private Placement Offering
08/10/2008
BioSpecifics Technologies Corp. Reports Second Quarter 2008 Financial Results
06/02/2008
BioSpecifics Technologies Corp. Announces Sale of Stock in Private Placement Offering
02/04/2008
BioSpecifics Technologies Corp. Announces Repayment of Outstanding Loan
01/13/2008
BioSpecifics Technologies Corp. Announces Sale of Stock in Private Placement Offering
10/19/2007
BioSpecifics to Present at the 9th Annual Healthcare Conference of Acumen Bio Fin Rodman Renshaw LLC
02/20/2007
BioSpecifics Technologies Corp. Mourns Death of Chairman and CEO Edwin H. Wegman
03/08/2006
Change in Assets, Financial Statements & Exhibits
